ATE265451T1 - 2-aminoidan derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen - Google Patents

2-aminoidan derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen

Info

Publication number
ATE265451T1
ATE265451T1 AT98400469T AT98400469T ATE265451T1 AT E265451 T1 ATE265451 T1 AT E265451T1 AT 98400469 T AT98400469 T AT 98400469T AT 98400469 T AT98400469 T AT 98400469T AT E265451 T1 ATE265451 T1 AT E265451T1
Authority
AT
Austria
Prior art keywords
alkyl
production
pharmaceutical compositions
compositions containing
heterocyclic rings
Prior art date
Application number
AT98400469T
Other languages
English (en)
Inventor
Jean-Louis Peglion
Bertrand Goument
Mark Millan
Alain Gobert
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of ATE265451T1 publication Critical patent/ATE265451T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
AT98400469T 1997-02-27 1998-02-27 2-aminoidan derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen ATE265451T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9702360A FR2760014B1 (fr) 1997-02-27 1997-02-27 Nouveaux composes de 2-amino indane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
ATE265451T1 true ATE265451T1 (de) 2004-05-15

Family

ID=9504253

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98400469T ATE265451T1 (de) 1997-02-27 1998-02-27 2-aminoidan derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen

Country Status (19)

Country Link
US (1) US5968954A (de)
EP (1) EP0861837B1 (de)
JP (1) JPH10237071A (de)
CN (1) CN1090627C (de)
AT (1) ATE265451T1 (de)
AU (1) AU725756B2 (de)
BR (1) BR9800763A (de)
CA (1) CA2231025C (de)
DE (1) DE69823411T2 (de)
DK (1) DK0861837T3 (de)
ES (1) ES2219853T3 (de)
FR (1) FR2760014B1 (de)
HK (1) HK1014945A1 (de)
HU (1) HU224312B1 (de)
NO (1) NO314307B1 (de)
NZ (1) NZ329853A (de)
PL (1) PL190240B1 (de)
PT (1) PT861837E (de)
ZA (1) ZA981680B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR022229A1 (es) 1999-01-12 2002-09-04 Abbott Gmbh & Co Kg Compuestos de triazol, composicion farmaceutica que los comprende y uso de los mismos para preparar dicha composicion
AU2002217742B2 (en) * 2001-01-16 2008-02-21 Astrazeneca Ab Therapeutic heterocyclic compounds
SE0103650D0 (sv) * 2001-11-01 2001-11-01 Astrazeneca Ab Therapeutic heterocyclic compounds
US7504395B2 (en) * 2001-07-20 2009-03-17 Psychogenics, Inc. Treatment for attention-deficit hyperactivity disorder
JP2005343790A (ja) * 2002-05-31 2005-12-15 Ajinomoto Co Inc カルシウムチャネル拮抗薬を含有する医薬組成物
US20050165025A1 (en) * 2004-01-22 2005-07-28 Recordati Ireland Ltd. Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists
WO2006062063A1 (ja) * 2004-12-08 2006-06-15 Astellas Pharma Inc. ピペリジン誘導体及びその製造法
UY29892A1 (es) * 2005-11-04 2007-06-29 Astrazeneca Ab Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones
WO2020183011A1 (en) 2019-03-14 2020-09-17 Institut Curie Htr1d inhibitors and uses thereof in the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9318431D0 (en) * 1993-09-06 1993-10-20 Boots Co Plc Therapeutic agents
FR2734819B1 (fr) * 1995-05-31 1997-07-04 Adir Nouveaux composes de la piperazine, de la piperidine et de la 1,2,5,6-tetrahydropyridine, leur procede de preparation et les compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
BR9800763A (pt) 1999-12-07
JPH10237071A (ja) 1998-09-08
HU9800422D0 (en) 1998-04-28
DE69823411D1 (de) 2004-06-03
CN1090627C (zh) 2002-09-11
PT861837E (pt) 2004-07-30
ZA981680B (en) 1998-09-04
HK1014945A1 (en) 1999-10-08
ES2219853T3 (es) 2004-12-01
FR2760014A1 (fr) 1998-08-28
HU224312B1 (hu) 2005-07-28
NO980803D0 (no) 1998-02-26
NO314307B1 (no) 2003-03-03
AU725756B2 (en) 2000-10-19
CN1194983A (zh) 1998-10-07
NO980803L (no) 1998-08-28
US5968954A (en) 1999-10-19
PL324982A1 (en) 1998-08-31
FR2760014B1 (fr) 1999-04-09
CA2231025C (fr) 2003-09-16
PL190240B1 (pl) 2005-11-30
DK0861837T3 (da) 2004-08-16
EP0861837B1 (de) 2004-04-28
NZ329853A (en) 1999-01-28
AU5635998A (en) 1998-09-03
DE69823411T2 (de) 2005-02-17
EP0861837A1 (de) 1998-09-02
HUP9800422A1 (hu) 1999-12-28
CA2231025A1 (fr) 1998-08-27

Similar Documents

Publication Publication Date Title
FR2654104B1 (fr) Nouveaux derives du 1,2-benzisoxazole, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
ATE89263T1 (de) Naphthalin-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE128458T1 (de) Naphtylalkylamine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
BR9803295A (pt) preparos e composições farmacêuticas contendo os mesmos.
ES530901A0 (es) Procedimiento para preparar derivados de piperazina
ES2093332T3 (es) Nuevos derivados arilglicinamidicos, su procedimiento de preparacion y su uso para el tratamiento de la disuria.
DE58904143D1 (de) Arylalkoxycumarine, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel.
ATE265451T1 (de) 2-aminoidan derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
CA2251003A1 (fr) Nouveaux composes derives de n-aryl 2-hydroxy alkylamides
ATE202564T1 (de) Aminomethylheterozyclischederivate, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
ZA964842B (en) Indole indazole and benzisoxazole compounds their process of preparation and the pharmaceutical compositions which contain them
FI940031A (fi) Uusia 2-syaani-3-hydroksipropenamidijohdannaisia, menetelmä niiden valmistamiseksi, niiden käyttö lääkkeinä ja niitä sisältävät farmaseuttiset koostumukset
ATE201020T1 (de) Benzopyranderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
ES2065192T3 (es) Nuevos nicotinatos de diacil-glicerol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ATE189810T1 (de) Eine trifluormethylsulfonylphenyl- oder trifluormethylsulfinylphenylgruppe enthaltende 2- cyan-3-hydroxy-propenamidderivate, verfahren zu ihrer herstellung, ihre anwendung als arzneimittel und diese enthaltende pharmazeutische zusammensetzungen
RS50790B (sr) Korišćenje derivata piridoindolona za spravljanje lekova
ATE195936T1 (de) Bis-imide derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitung
ATE199897T1 (de) Aminierte 6,7,8,9-tetrahydro- cyclopenta(a)naphthalen- und 2,3-dihydro- cyclopenta(e)inden-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
ATE433439T1 (de) Anthranyl-derivate mit anti-cholecystokinin- aktivität (anti-cck-1) verfahren zu deren herstellung und deren pharmazeutische anwendung
ATE140216T1 (de) (cyclohexyl)alkenderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
ATE281453T1 (de) 4-amino-2-ureido-pyrimidin-5-carbonsäureamide, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0861837

Country of ref document: EP

REN Ceased due to non-payment of the annual fee